# Perceived Changes in Anxiety Symptom Burden During Treatment With Bryophyllum Pinnatum and Tolerability

> **NCT04825171** · PHASE4 · COMPLETED · sponsor: **Markus Schlemmer** · enrollment: 51 (actual)

## Conditions studied

- Anxiety Symptoms

## Interventions

- **DRUG:** Bryophyllum 50 % Chewing Tablets

## Key facts

- **NCT ID:** NCT04825171
- **Lead sponsor:** Markus Schlemmer
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-31
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2024-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04825171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04825171, "Perceived Changes in Anxiety Symptom Burden During Treatment With Bryophyllum Pinnatum and Tolerability". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04825171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
